THE D-1 DOPAMINE RECEPTOR PARTIAL AGONIST, CY 208-243, EXHIBITS ANTIPARKINSONIAN ACTIVITY IN THE MPTP-TREATED MARMOSET

被引：59
|
作者：
TEMLETT, JA
PIANG, NC
OERTEL, WH
JENNER, P
MARSDEN, CD
机构：
[1] UNIV LONDON,DEPT NEUROL,MRC,MOVEMENT DISORDERS RES GRP,LONDON SE5 8AF,ENGLAND
[2] INST PSYCHIAT,PARKINSONS DIS SOC RES CTR,LONDON SE5,ENGLAND
[3] UNIV LONDON KINGS COLL HOSP,SCH MED,LONDON SE5 8RX,ENGLAND
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1988年 / 156卷 / 02期
关键词：
D O I：
10.1016/0014-2999(88)90322-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：197 / 206
页数：10
相关论文
共 50 条
  • [21] DIFFERENTIAL-EFFECTS OF D-1 AND D-2 DOPAMINE AGONISTS IN MPTP-TREATED SQUIRREL-MONKEYS
    BOYCE, S
    RUPNIAK, NMJ
    STEVENTON, MJ
    IVERSEN, SD
    PSYCHOPHARMACOLOGY, 1990, 101 : S7 - S7
  • [22] HYPOTHALAMO-HYPOPHYSEAL-GONADAL FUNCTION IN THE RAT FOLLOWING ADMINISTRATION OF THE NOVEL AND SELECTIVE D-1 AGONIST CY-208-243
    SIEGEL, RA
    MARKO, M
    EXPERIENTIA, 1988, 44 (09): : 764 - 766
  • [23] The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa
    Michael John Jackson
    Terrance H. Andree
    Matthew Hansard
    Diane C. Hoffman
    Mark R. Hurtt
    John H. Kehne
    Thomas A. Pitler
    Lance A. Smith
    Gary Stack
    Peter Jenner
    Journal of Neural Transmission, 2010, 117 : 55 - 67
  • [24] The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa
    Jackson, Michael John
    Andree, Terrance H.
    Hansard, Matthew
    Hoffman, Diane C.
    Hurtt, Mark R.
    Kehne, John H.
    Pitler, Thomas A.
    Smith, Lance A.
    Stack, Gary
    Jenner, Peter
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (01) : 55 - 67
  • [25] The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration
    Smith, LA
    Jackson, MJ
    Al-Barghouthy, G
    Jenner, P
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (02) : 123 - 140
  • [26] The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration
    L. A. Smith
    M. J. Jackson
    G. Al-Barghouthy
    P. Jenner
    Journal of Neural Transmission, 2002, 109 : 123 - 140
  • [27] A-77636 - A POTENT AND SELECTIVE DOPAMINE-D1 RECEPTOR AGONIST WITH ANTIPARKINSONIAN ACTIVITY IN MARMOSETS
    KEBABIAN, JW
    BRITTON, DR
    DENINNO, MP
    PERNER, R
    SMITH, L
    JENNER, P
    SCHOENLEBER, R
    WILLIAMS, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (2-3) : 203 - 209
  • [28] NEW PUTATIVE SELECTIVE AGONISTS AT THE D-1 DOPAMINE RECEPTOR - BEHAVIORAL AND NEUROCHEMICAL COMPARISON OF CY-208-243 WITH SK-AND-F-101384 AND SK-AND-F-103243
    MURRAY, AM
    WADDINGTON, JL
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (01) : 105 - 110
  • [29] MOTOR-ACTIVITY FOLLOWING THE ADMINISTRATION OF SELECTIVE D-1 AND D-2 DOPAMINERGIC DRUGS TO MPTP-TREATED COMMON MARMOSETS
    LOSCHMANN, PA
    SMITH, LA
    LANGE, KW
    JAHNIG, P
    JENNER, P
    MARSDEN, CD
    PSYCHOPHARMACOLOGY, 1992, 109 (1-2) : 49 - 56
  • [30] Ropinirole, bromocriptine and L-dopa have a differential effect on striatal dopamine D-2 and D-3 but not D-1 receptor mRNA expression in MPTP-treated marmosets
    Tel, BC
    Rose, S
    Jenner, P
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136
12345